Lactoferrin (LF) / Bovine lactoferrin (bLF)
Iron-binding glycoprotein with broad antimicrobial, anti-inflammatory, and immunomodulatory activity.
At a glance
What it is: Iron-binding glycoprotein with broad antimicrobial, anti-inflammatory, and immunomodulatory activity..
Primary research applications:
- Antimicrobial / gut health support
- Iron status improvement (oral)
- Neonatal sepsis prevention research
Editorial summary: Lactoferrin is technically a protein (around 80 kDa) rather than a small peptide, but it is widely discussed in peptide and supplement contexts. Its biology is genuinely interesting: an iron-binding glycoprotein in milk and other secretions with broad antimicrobial, anti-inflammatory, and immunomodulatory effects. Oral bovine lactoferrin has the most clinical traction, with neonatal sepsis prevention representing the most promising — though not yet definitive — application.
- Class / structure
- ~80 kDa iron-binding glycoprotein; bovine lactoferrin commonly used clinically
- Half-life
- Variable by tissue and route
- First described
- 1939 (isolated from cow's milk by Sørensen and Sørensen)
- Regulatory status
- Sold as a dietary supplement in many countries; some pharmaceutical-grade preparations
What is Lactoferrin?
Lactoferrin is an iron-binding glycoprotein of the transferrin family. Its iron-sequestering capacity contributes to antimicrobial activity (depriving pathogens of iron), and several active fragments — particularly lactoferricin — have direct membrane-disruptive antimicrobial effects.
Discovery and development
Lactoferrin was first isolated from cow's milk in 1939 and has been the subject of extensive research as one of the most abundant and biologically active proteins in mammalian secretions. It is found at especially high concentrations in human colostrum and at lower levels in mature breast milk, neutrophil granules, tears, saliva, and mucosal secretions throughout the body.
Mechanism of action
Lactoferrin's biology spans multiple pathways:
- Iron sequestration — limits availability for pathogen growth.
- Direct antimicrobial activity — particularly via the lactoferricin fragment, which disrupts microbial membranes.
- Immunomodulation — modulates dendritic cell function, T-cell differentiation, and cytokine signaling.
- Iron absorption support — in oral use, lactoferrin can support iron absorption in iron-deficient states.
Pharmacokinetics
Oral bovine lactoferrin is partially resistant to digestion, with bioactive fragments (notably lactoferricin) being generated by gastric pepsin cleavage. Some intact lactoferrin reaches the small intestine and is detectable in stool. Systemic absorption is modest; most clinical effects are believed to occur at mucosal surfaces and via gut-associated lymphoid tissue.
What the research shows
The peer-reviewed literature on Lactoferrin is summarized below across two tiers: human research (the highest standard), and preclinical / emerging research (animal models and early-stage human work).
Claims and the evidence behind them
This table summarizes commonly discussed claims and how the published evidence weighs in. The aim is clarity — supported claims, claims that look promising but need more data, and claims that outrun the science.
| Claim | What the evidence shows | Verdict |
|---|---|---|
| Has antimicrobial activity in vitro | Extensive literature | Supported |
| Improves iron status in iron-deficient adults | Multiple controlled trials | Promising |
| Reduces sepsis in preterm neonates | Mixed Cochrane verdict; some positive trials | Promising |
| Boosts immunity broadly in healthy adults | Mechanistic plausibility; clinical efficacy in healthy populations is less established | Mixed |
Reported user experiences
How the research describes administration
Most commonly administered orally as bovine lactoferrin. Pharmaceutical-grade and high-purity supplement forms vary considerably in quality.
Editorial note
Administration details above describe how the peptide is given in published studies. We summarize this for educational completeness — these descriptions are not protocols, dosing recommendations, or instructions for personal use. Decisions about treatment require an appropriately licensed clinician.
Safety considerations and open questions
The takeaway
Lactoferrin sits between the supplement and pharmaceutical worlds — a genuinely biologically active milk protein with credible antimicrobial, anti-inflammatory, and iron-support properties. The most rigorous research supports its use in specific clinical contexts (neonatal care, iron deficiency); broader claims for general health and immune support extrapolate beyond the strongest evidence. As with any supplement, source quality matters.
Frequently asked questions
Is lactoferrin a peptide?
Strictly, it is a protein (~80 kDa, much larger than typical peptides). It is included in peptide-context discussion because of its biological activities and because some active fragments (lactoferricin) are themselves peptides.
Does lactoferrin help fight COVID or other viruses?
In vitro and small clinical-trial data has suggested antiviral activity for some pathogens. The evidence specifically for COVID-19 is mixed and has not supported confident claims at clinical-evidence levels.
References
- Legrand D. Overview of lactoferrin as a natural immune modulator. J Pediatr. 2016;173 Suppl:S10-S15. https://pubmed.ncbi.nlm.nih.gov/27234406/
- Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2020;3:CD007137. https://pubmed.ncbi.nlm.nih.gov/32232984/